Guide

Long-term maintenance and discontinuation

Obesity is a chronic disease. Default is long-term continuation. Discontinuation produces regain (STEP-4).

Released: · Last reviewed:

What happens if you stop taking a GLP-1?

Most people regain weight after stopping: in the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year, and in SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of body weight while those who continued lost 5.5% more. Blood pressure, blood sugar and cholesterol improvements also tended to fade. Talk with your clinician before stopping, and plan for diet, activity and follow-up. If cost is the reason, ask about a lower maintenance dose or a different payment route.

Answer dated October 16, 2026; reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).

Obesity is a chronic disease. Default is long-term continuation. Discontinuation produces regain (STEP-4).

STEP-4 finding

STEP-4 (JAMA 2021) randomized patients completing 20 weeks of semaglutide titration to continue vs placebo. Continuation: additional weight loss to ~17%. Withdrawal: ~7% regain. This is why obesity is framed as chronic disease.

Implications

The question is not 'when do I stop' but 'how do I make this sustainable.' Plan cost, refill logistics, side-effect management, lifestyle support.

If you discontinue

When appropriate

Maintenance dose decisions

Many patients stabilize at sub-maximum producing target effect with acceptable side effects. Going to max just because available is not required.

P

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.